Abstracts

IMPROVED HEMATOLOGICAL OUTCOMES WITH NEVIRAPINE FOR INFANT HIV POSTNATAL PROPHYLAXIS

With combination antiretroviral therapy (cART) in HIV-infected women, mother-to-child transmission rates declined to less than 1%. For post-natal infant prophylaxis, in situations of low risk of perinatal HIV transmission, high income countries use zidovudine (ZDV), whereas low income countries use either nevirapine (NVP) or ZDV. Given the low transmission risk and the concerns about the…

CHANGES IN DTG USE FOLLOWING THE NTD SAFETY SIGNAL IN BOTSWANA

In May 2018 a preliminary safety signal for neural tube defects among women on dolutegravir (DTG) at conception led to in-country guidance for individualized counseling for pregnant women who had already conceived on DTG and women on DTG or starting antiretroviral treatment (ART) who desired pregnancy; DTG-based ART otherwise remained the recommended regimen for new ART starts.…

MOTIVATIONAL INTERVIEWING RETENTION COUNSELING AND CHILD HIV TESTING IN SOUTH AFRICA

The improvement of health outcomes of vertically infected infants requires earlier HIV diagnosis through greater adherence to the HIV testing schedules for HIV-exposed children.   This is a randomised controlled trial among HIV positive postpartum mother-baby dyads enrolled immediately after the postnatal consultation at four midwife obstetric units in Gauteng (South Africa) and randomised into…

EARLY INFANT DIAGNOSIS: STRENGTHEN EXISTING SYSTEMS OR INVEST IN POINT-OF-CARE?

To improve early infant HIV diagnosis (EID) programs, options include replacing lab-based tests with point-of-care (POC) assays or investing in strengthened systems for sample transport and return of results. We projected the clinical benefits and cost-effectiveness of these approaches. We used the Cost-Effectiveness of Preventing AIDS Complications-Pediatric model, with programmatic and published data, to examine…